Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplified versus divided-dose tranexamic acid regimen in traumatic hemorrhagic shock
ChiCTR2600134048Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in post-traumatic hemorrhage and hemorrhagic shock (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Incidence of inpatient thrombotic events and Hospital-free days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
post-traumatic hemorrhagehemorrhagic shock
Beyond the preview
Go deeper on ChiCTR2600134048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134048.